SCHEMBL342407

SCHEMBL342407

Nc1cccc2cc(C(=O)O)cc(O)c12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
PTPN11 Q06124 3/20 0.45
RNASEH1 O60930 1/20 0.45
GPR35 Q9HC97 1/20 0.45
ATG4B Q9Y4P1 1/20 0.45
CA12 O43570 4/20 0.44
CA1 P00915 4/20 0.44
CA2 P00918 4/20 0.44
CA9 Q16790 4/20 0.44
CA6 P23280 3/20 0.44
CA7 P43166 3/20 0.44
CA14 Q9ULX7 3/20 0.44
KDM4E B2RXH2 3/20 0.44
MAPT P10636 3/20 0.44
HSD17B10 Q99714 3/20 0.44
ALDH1A1 P00352 3/20 0.44
CA4 P22748 2/20 0.44
LMNA P02545 2/20 0.44
HPGD P15428 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11481468 0.86 MEN1 (0.63) MEN1KMT2APTPN11RNASEH1GPR35
SCHEMBL3389929 0.84 KMT2A (0.66) MEN1KMT2APTPN11RNASEH1GPR35
SCHEMBL342924 0.82 CA12 (0.50) MEN1KMT2APTPN11RNASEH1GPR35
SCHEMBL12193739 0.79 MEN1 (0.59) MEN1KMT2APTPN11RNASEH1GPR35
SCHEMBL342406 0.79 MEN1 (0.59) MEN1KMT2APTPN11RNASEH1GPR35
SCHEMBL24895075 0.79 MEN1 (0.59) MEN1KMT2APTPN11RNASEH1GPR35
SCHEMBL5735611 0.79 KMT2A (0.50) MEN1KMT2APTPN11RNASEH1GPR35
Hydrochloric Acid SCHEMBL5734772 0.78 KMT2A (0.49) MEN1KMT2APTPN11RNASEH1GPR35
Hydrochloric Acid SCHEMBL5737488 0.78 KMT2A (0.49) MEN1KMT2APTPN11RNASEH1GPR35
SCHEMBL29257012 0.77 PTPN11 (0.56) PTPN11CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2420538-B1 PORPHYRAZINE DYE, INK COMPOSITION CONTAINING SAME, AND COLORED BODY NIPPON KAYAKU KK (JP) 2015-04-22 EP disclosed
CN-102395629-B Porphyrazine dye, ink composition containing same, and colored article NIPPON KAYAKU KK 2014-05-14 CN disclosed
US-8535432-B2 Porphyrazine coloring matter, ink composition containing the same and colored product NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-09-17 US disclosed
CN-102395629-A Porphyrazine dye, ink composition containing same, and colored article NIPPON KAYAKU KK 2012-03-28 CN disclosed
EP-2420538-A1 PORPHYRAZINE DYE, INK COMPOSITION CONTAINING SAME, AND COLORED BODY Nippon Kayaku Kabushiki Kaisha (JP) 2012-02-22 EP disclosed
US-20120013678-A1 Porphyrazine Coloring Matter, Ink Composition Containing The Same And Colored Product NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-01-19 US disclosed
US-20090306201-A1 SELECTIVE INHIBITORS FOR TRANSFERASES UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2009-12-10 US disclosed
US-20090306201-A1 SELECTIVE INHIBITORS FOR TRANSFERASES UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2009-12-10 US disclosed
WO-2007149782-A2 SELECTIVE INHIBITORS FOR TRANSFERASES UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306201-A1 SELECTIVE INHIBITORS FOR TRANSFERASES TYMP, PCNA, TK1 MEN1 2046/4885KMT2A 426/4885PTPN11 3419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.